AAV-ShH10Y445F Serotype
ShH10 variant with Y445F tyrosine mutation for enhanced intracellular trafficking and 2-5 fold improved transduction in liver and muscle.
| Tropism | Liver (enhanced), muscle, CNS |
|---|
Characteristics
Y445F tyrosine mutation reducing ubiquitination. Enhanced intracellular trafficking. 2-5 fold transduction improvement versus wild-type ShH10. Maintained broad tropism profile. Reduced vector dose requirements.
Applications
Hemophilia B clinical development. Enhanced liver-directed gene therapy. Applications requiring improved transduction efficiency.
Sequence1 bp
Sign in to view the full sequence.
Sign inReferences
- 1.Hauck et al. (2020). Generation and characterization of chimeric recombinant AAV vectors. Mol Ther Methods Clin Dev — Hauck 2020 ShH10-Y445F
